摘要:
The invention provides systematic methods for identification of candidate compounds useful in treatment of conditions initiated or modulated by genetic expression. The methods of the invention permit efficient identification of candidates suitable for verification testing by in vitro and/or in vivo models.
摘要:
A compound of formula I: or solvate thereof, wherein n is 1 to 10, and M and M′ are independently selected from monovalent pharmaceutically acceptable cations, or together represent a divalent pharmaceutically acceptable cation.
摘要:
A compound of the formula II: wherein: R′2 is CHR″2, where R″2 is H. R6 and R9 are H and R7 is OMe and the compound is a dimer with each monomer being the same and being of formula II, where the R8 groups of the monomers form together a bridge having the formula —O—(CH2)p—O—, where p is 5, linking the monomers.
摘要:
A compound of formula I: or solvate thereof, wherein n is 1 to 10, and M and M′ are independently selected from monovalent pharmaceutically acceptable cations, or together represent a divalent pharmaceutically acceptable cation.
摘要:
A compound of formula (I) and salts and solvates thereof, wherein: R10 is a nitrogen protecting group and R11 is either OH or O—R12, wherein R12 is an oxygen protecting group, or R10 and R11 together form a double bond between N10 and C11; and R10′ and R11′ are selected from the same options as R10 and R11 respectively.
摘要:
Disclosed are compounds of Formula (I) wherein X, Y, Ri-R7,T1, T2, Z, and p are as described herein; a pharmaceutical composition comprising a compound of Formula (I) and a carrier; a method of inhibiting growth of a cell, which method comprises administering in an amount effective to inhibit growth a compound of Formula (I); a method of treating cancer in a mammal, which method comprises administering in an amount effective to treat cancer a compound of Formula (I); a method of treating a viral, parasitic, or bacterial infection of a cell, which method comprises administering in an amount effective to treat a viral, parasitic, or bacterial infection a compound of Formula (I); and a method of preparing a compound of Formula (I) as described herein.
摘要:
Compounds of formula (I): formula (I) and salts, solvates, chemically protected forms, and prodrugs thereof, are C disclosed wherein R2 is selected from: an optionally substituted napthyl group; an optionally substituted thiophenyl or furanyl group; and a phenyl group substituted by: one or more chloro or fluoro groups; an ethyl or propyl group; a 4-t-butyl group; a 2-methyl group; or two methyl groups in the 2- and 6- positions.
摘要:
A process for preparing at least two compositions suitable for production of gasoline, which process comprises: fractionating an alkylation product to produce a first cut boiling in the range 90-106° C., a second cut boiling at temperature lower than said first cut, and a third cut boiling at a temperature above said first Cut, blending at least 2% by volume of said first cut with at least 5% of a component selected from at least one of a paraffin, an aromatic hydrocarbon and an olefinic hydrocarbon, said component having a boiling point of 60-160° C., wherein not more than 5% of the total composition of hydrocarbon has a boiling point of more than 160° C. and wherein said composition comprises less than 5% of 2,2,3-trimethylbutane or 2,2,3-trimethylpentane, to produce a first high octane unleaded gasoline composition of RON at least 97 and MON value at least 86, and incorporating said second and third cuts with said component to produce a second high octane unleaded gasoline composition of RON at least 92 and MON value at least 80.
摘要:
A process for the production of acetic acid, which process comprises contacting ethane and/or ethylene with a molecular oxygen-containing gas in a fluid bed reactor in the presence of a microspheroidal fluidised particulate solid oxidation catalyst, wherein at least 90% of said catalyst particles are less than 300 microns.
摘要:
A process for preparing polyolefins having at least 0.01 long chain branches (LCB)/1000 carbon atoms along the polymer backbone as measured by flow activation and a molecular weight distribution greater than 2.5 comprises polymerization in the presence of a metallocene complex having the formula: wherein Cp1, Cp2 are independently a substituted or unsubstituted indenyl or hydrogenated indenyl group, Y is a univalent anionic ligand, M is zirconium, titanium or hafnium, and Z is a bridging group comprising an alkylene group having 1 to 20 carbon atoms or a dialkyl silyl- or germyl- group, or alkyl phophine or amine radical. Polyolefins prepared from such a process show specific flow activation energy/LCB relationships.